← Open Payments lookup

ROBERT SUMMEROUR: Open Payments

NPI 1811085160 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,105 in 52 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $832 · 2025 $1,105

Food & beverage: $1,105
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.10$216
Teva Pharmaceuticals USA, Inc.11$202
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$151
Alkermes, Inc.7$141
Otsuka America Pharmaceutical, Inc.4$96
ABBVIE INC.4$86
Janssen Pharmaceuticals, Inc2$55
Vanda Pharmaceuticals Inc.2$46
Almatica Pharma LLC1$27
Lundbeck LLC1$22

Products named: INGREZZA, CAPLYTA, ARISTADA, AUSTEDO XR, REXULTI, VRAYLAR, UZEDY, INVEGA SUSTENNA.

Industry payments across CA — which companies pay providers there.